 |
PDBsum entry 2fsl
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Mitogen activated protein kinase p38alpha (d176a+f327s) activating mutant form-a
|
|
Structure:
|
 |
Mitogen-activated protein kinase 14. Chain: x. Synonym: mitogen-activated protein kinase p38 alpha, map kinase p38 alpha, cytokine suppressive anti-inflammatory drug binding protein, csaid-binding protein, csbp, max-interacting protein 2, map kinase mxi2, sapk2a. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
1.70Å
|
R-factor:
|
0.220
|
R-free:
|
0.240
|
|
|
Authors:
|
 |
R.Diskin,O.Livnah
|
Key ref:
|
 |
R.Diskin
et al.
(2007).
Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation.
J Mol Biol,
365,
66-76.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Jan-06
|
Release date:
|
05-Dec-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q16539
(MK14_HUMAN) -
Mitogen-activated protein kinase 14 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
360 a.a.
332 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.24
- mitogen-activated protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
365:66-76
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structures of p38alpha active mutants reveal conformational changes in L16 loop that induce autophosphorylation and activation.
|
|
R.Diskin,
M.Lebendiker,
D.Engelberg,
O.Livnah.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
p38 mitogen-activated protein (MAP) kinases function in numerous signaling
processes and are crucial for normal functions of cells and organisms. Abnormal
p38 activity is associated with inflammatory diseases and cancers making the
understanding of its activation mechanisms highly important. p38s are commonly
activated by phosphorylation, catalyzed by MAP kinase kinases (MKKs). Moreover,
it was recently revealed that the p38alpha is also activated via alternative
pathways, which are MKK independent. The structural basis of p38 activation,
especially in the alternative pathways, is mostly unknown. This lack of
structural data hinders the study of p38's biology as well as the development of
novel strategies for p38 inhibition. We have recently discovered and optimized a
novel set of intrinsically active p38 mutants whose activities are independent
of any upstream activation. The high-resolution crystal structures of the
intrinsically active p38alpha mutants reveal that local alterations in the L16
loop region promote kinase activation. The L16 loop can be thus regarded as a
molecular switch that upon conformational changes promotes activation. We
suggest that similar conformational changes in L16 loop also occur in natural
activation mechanisms of p38alpha in T-cells. Our biochemical studies reveal
novel mechanistic insights into the activation process of p38. In this regard,
the results indicate that the activation mechanism of the mutants involves
dimerization and subsequent trans autophosphorylation on Thr180 (on the
phosphorylation lip). Finally, we suggest a model of in vivo p38alpha activation
induced by the L16 switch with auto regulatory characteristics.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Phosphorylation on Thr180 of recombinant p38α^D176A
+ F327L is temperature-dependent. (a) Kinase assay of p38α^wt
and p38α^D176A + F327L purified from cultures grown at
different temperatures. The assay measures the ability of the
enzymes to phosphorylate in vitro the GST-ATF2 protein substrate
using [γ-^32P]ATP. Coomassie staining (upper image) verified
the amount of substrate in each lane. The radiograph (lower
image) reveals the activity. (b) The active p38α variant is
threonine phosphorylated. To elucidate phosphorylation we
preformed Western blot analysis utilizing specific anti-phospho
antibodies (anti-phospho-Thr, anti-phospho-Tyr and
anti-phospho-p38). The small arrows indicate the migration
height of p38α in gel electrophoresis. Anti-p38α antibody was
used to determine the amount of p38 loaded at each lane. Some
minor phosphorylation on tyrosine residues can be seen only on
smaller proteolytic products (marked with asterisks). Yet, these
proteins also interacted with the anti-phospho-p38 antibody.
(c) The p38α^D176A + F327L molecule exhibits
autophosphorylation in vitro. Purified p38α^D176A + F327L that
was also used for crystallization was incubated in a kinase
assay buffer without substrate for increasing time intervals at
30 °C. Coomassie staining (upper image) verified the amount
of enzyme in each lane. The radiograph (lower image) reveals
phosphorylation. (d) Mono-phosphorylated p38α is catalytically
active. We measured kinase activity toward GST-ATF2 of
p38α^Y182F, p38α^T180A and p38α^wt activated or not in vitro
by MKK6. Coomassie staining (upper image) verified the amount
of GST-ATF2 in each lane. The radiograph (lower image)
indicates activity. Figure 1. Phosphorylation on Thr180 of
recombinant p38α^D176A + F327L is temperature-dependent. (a)
Kinase assay of p38α^wt and p38α^D176A + F327L purified from
cultures grown at different temperatures. The assay measures the
ability of the enzymes to phosphorylate in vitro the GST-ATF2
protein substrate using [γ-^32P]ATP. Coomassie staining (upper
image) verified the amount of substrate in each lane. The
radiograph (lower image) reveals the activity. (b) The active
p38α variant is threonine phosphorylated. To elucidate
phosphorylation we preformed Western blot analysis utilizing
specific anti-phospho antibodies (anti-phospho-Thr,
anti-phospho-Tyr and anti-phospho-p38). The small arrows
indicate the migration height of p38α in gel electrophoresis.
Anti-p38α antibody was used to determine the amount of p38
loaded at each lane. Some minor phosphorylation on tyrosine
residues can be seen only on smaller proteolytic products
(marked with asterisks). Yet, these proteins also interacted
with the anti-phospho-p38 antibody. (c) The p38α^D176A + F327L
molecule exhibits autophosphorylation in vitro. Purified
p38α^D176A + F327L that was also used for crystallization was
incubated in a kinase assay buffer without substrate for
increasing time intervals at 30 °C. Coomassie staining
(upper image) verified the amount of enzyme in each lane. The
radiograph (lower image) reveals phosphorylation. (d)
Mono-phosphorylated p38α is catalytically active. We measured
kinase activity toward GST-ATF2 of p38α^Y182F, p38α^T180A and
p38α^wt activated or not in vitro by MKK6. Coomassie staining
(upper image) verified the amount of GST-ATF2 in each lane. The
radiograph (lower image) indicates activity.
|
 |
Figure 3.
Figure 3. Conformational changes in the L16 loop and disruption
of a salt-bridge are fingerprints of the active p38α
molecules. (a) The conformational changes within the L16 loops
of p38α^D176A + F327L (blue) and p38α^D176A + F327S (yellow)
in reference to p38α^D176A (magenta) and p38α^wt (gray).
Mutations of Phe327 to serine or leucine results in a
conformational change in the L16 loop. Residues 327 in the
mutants' structures subsequently adopt a different conformation.
However, the conformation of Trp337 and Tyr69 remains highly
similar in all structures. (b) Segments of L16 loop from
p38α^D176A (left), p38α^D176A + F327L (center) and p38α^D176A
+ F327S (right) are superimposed with p38α^wt as a reference.
The conformation of the L16 loop in the structure of p38α^D176A
is almost identical (except minor changes in Asp331) to that of
p38α^wt. Mutation of Phe327 leads to the unwinding and a shift
of the main-chain helical conformation in the L16, and
subsequently the side-chains of residues 324 to 330 adopt a
different position in both p38α^D176A + F327L and p38α^D176A +
F327S models (center and right). (c) A salt bridge interaction
is formed between the negatively charged carboxyl group of
Glu328 and the positively charged guanidine of Arg70 (green
broken lines) in both p38α^wt and p38α^D176A (left). This salt
bridge is disrupted in the structures of p38α^D176A + F327L
and p38α^D176A + F327S (center and right, respectively) due to
the conformational change in the L16 loop. In this regard, the
unpaired Arg70 acquire new conformations; in p38α^D176A + F327L
Arg70 adopts a dual conformation whereas in p38α^D176A + F327S
only one. The C^α atom of Glu328 is shifted 2.53 Å and
1.11 Å in the structures of p38α^D176A + F327L and
p38α^D176A + F327S, respectively, relative to the p38α^wt
structure. The orientation of the side-chains is somewhat
different as Lys66 is stabilizing the carbonyl oxygen of Glu328
by forming an H-bond interaction in p38α^D176A + F327S similar
to p38α^wt but not in p38α^D176A + F327L (yellow broken
lines). Figure 3. Conformational changes in the L16 loop and
disruption of a salt-bridge are fingerprints of the active p38α
molecules. (a) The conformational changes within the L16 loops
of p38α^D176A + F327L (blue) and p38α^D176A + F327S (yellow)
in reference to p38α^D176A (magenta) and p38α^wt (gray).
Mutations of Phe327 to serine or leucine results in a
conformational change in the L16 loop. Residues 327 in the
mutants' structures subsequently adopt a different conformation.
However, the conformation of Trp337 and Tyr69 remains highly
similar in all structures. (b) Segments of L16 loop from
p38α^D176A (left), p38α^D176A + F327L (center) and p38α^D176A
+ F327S (right) are superimposed with p38α^wt as a reference.
The conformation of the L16 loop in the structure of p38α^D176A
is almost identical (except minor changes in Asp331) to that of
p38α^wt. Mutation of Phe327 leads to the unwinding and a shift
of the main-chain helical conformation in the L16, and
subsequently the side-chains of residues 324 to 330 adopt a
different position in both p38α^D176A + F327L and p38α^D176A +
F327S models (center and right). (c) A salt bridge interaction
is formed between the negatively charged carboxyl group of
Glu328 and the positively charged guanidine of Arg70 (green
broken lines) in both p38α^wt and p38α^D176A (left). This salt
bridge is disrupted in the structures of p38α^D176A + F327L and
p38α^D176A + F327S (center and right, respectively) due to the
conformational change in the L16 loop. In this regard, the
unpaired Arg70 acquire new conformations; in p38α^D176A + F327L
Arg70 adopts a dual conformation whereas in p38α^D176A + F327S
only one. The C^α atom of Glu328 is shifted 2.53 Å and
1.11 Å in the structures of p38α^D176A + F327L and
p38α^D176A + F327S, respectively, relative to the p38α^wt
structure. The orientation of the side-chains is somewhat
different as Lys66 is stabilizing the carbonyl oxygen of Glu328
by forming an H-bond interaction in p38α^D176A + F327S similar
to p38α^wt but not in p38α^D176A + F327L (yellow broken
lines).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2007,
365,
66-76)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Ota,
J.Zhang,
P.Ping,
J.Han,
and
Y.Wang
(2010).
Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
|
| |
Circ Res,
106,
1404-1412.
|
 |
|
|
|
|
 |
R.Akella,
X.Min,
Q.Wu,
K.H.Gardner,
and
E.J.Goldsmith
(2010).
The third conformation of p38α MAP kinase observed in phosphorylated p38α and in solution.
|
| |
Structure,
18,
1571-1578.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Kumphune,
R.Bassi,
S.Jacquet,
P.Sicard,
J.E.Clark,
S.Verma,
M.Avkiran,
S.J.O'Keefe,
and
M.S.Marber
(2010).
A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580.
|
| |
J Biol Chem,
285,
2968-2975.
|
 |
|
|
|
|
 |
E.Aberg,
K.M.Torgersen,
B.Johansen,
S.M.Keyse,
M.Perander,
and
O.M.Seternes
(2009).
Docking of PRAK/MK5 to the Atypical MAPKs ERK3 and ERK4 Defines a Novel MAPK Interaction Motif.
|
| |
J Biol Chem,
284,
19392-19401.
|
 |
|
|
|
|
 |
L.Jirmanova,
D.N.Sarma,
D.Jankovic,
P.R.Mittelstadt,
and
J.D.Ashwell
(2009).
Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production.
|
| |
Blood,
113,
2229-2237.
|
 |
|
|
|
|
 |
M.Rincón,
and
R.J.Davis
(2009).
Regulation of the immune response by stress-activated protein kinases.
|
| |
Immunol Rev,
228,
212-224.
|
 |
|
|
|
|
 |
P.R.Mittelstadt,
H.Yamaguchi,
E.Appella,
and
J.D.Ashwell
(2009).
T cell receptor-mediated activation of p38{alpha} by mono-phosphorylation of the activation loop results in altered substrate specificity.
|
| |
J Biol Chem,
284,
15469-15474.
|
 |
|
|
|
|
 |
K.M.Sours,
S.C.Kwok,
T.Rachidi,
T.Lee,
A.Ring,
A.N.Hoofnagle,
K.A.Resing,
and
N.G.Ahn
(2008).
Hydrogen-exchange mass spectrometry reveals activation-induced changes in the conformational mobility of p38alpha MAP kinase.
|
| |
J Mol Biol,
379,
1075-1093.
|
 |
|
|
|
|
 |
J.E.Clark,
N.Sarafraz,
and
M.S.Marber
(2007).
Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease.
|
| |
Pharmacol Ther,
116,
192-206.
|
 |
|
|
|
|
 |
J.J.Gills,
S.S.Castillo,
C.Zhang,
P.A.Petukhov,
R.M.Memmott,
M.Hollingshead,
N.Warfel,
J.Han,
A.P.Kozikowski,
and
P.A.Dennis
(2007).
Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanisms.
|
| |
J Biol Chem,
282,
27020-27029.
|
 |
|
|
|
|
 |
M.Avitzour,
R.Diskin,
B.Raboy,
N.Askari,
D.Engelberg,
and
O.Livnah
(2007).
Intrinsically active variants of all human p38 isoforms.
|
| |
FEBS J,
274,
963-975.
|
 |
|
|
|
|
 |
M.Rincón,
and
R.J.Davis
(2007).
Choreography of MAGUKs during T cell activation.
|
| |
Nat Immunol,
8,
126-127.
|
 |
|
|
|
|
 |
R.Diskin,
D.Engelberg,
and
O.Livnah
(2007).
High-resolution diffracting crystals of intrinsically active p38alpha MAP kinase: a case study for low-throughput approaches.
|
| |
Acta Crystallogr D Biol Crystallogr,
63,
260-265.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |